FiercePharma

Actemra®, a Treatment for Rheumatoid Arthritis Obtained Approval for Subcutaneous Injection Formulation

March 25, 2013 (Tokyo) - Chugai Pharmaceutical Co., Ltd. [Head Office: Chuo-ku Tokyo; Chairman & CEO: Osamu Nagayama (hereafter, "Chugai")] announced today that the subcutaneous injection formulation ...
Monthly Prescribing Reference

Extended Release Ondansetron Comparable to Standard Injection for CINV

The study met the primary endpoint, demonstrating a complete response of 89% in the ondansetron extended release injection arm vs 82% in the standard ondansetron injection arm. Topline data were ...
Aidsmap

New formulations and alternative injection sites might allow self-administration of long-acting cabotegravir and rilpivirine

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
Nasdaq

Eisai: Antiepileptic Drug Fycompa Injection Formulation Approved in Japan

TOKYO, Jan 18, 2024 - (JCN Newswire) - - Eisai Co., Ltd. announced today that it has obtained marketing authorization approval from the Japanese Ministry of Health, Labour and Welfare for the ...
Monthly Prescribing Reference

New Formulation of Minocin for Injection Launched

The Medicines Company announced the launch of a new formulation of Minocin (minocycline) for Injection. The new formulation contains magnesium sulfate, an excipient, which allows for administration at ...
elEconomista

CyDex Announces Captisol Technology Used in Injection Formulation of Veterinary Anti-Emetic Cerenia(R) (Maropitant) Recently Approved for Marketing in Europe

contains CyDex's Captisol(R)-enabling technology. On September 29, 2006, the European Medicines Agency approved both the subcutaneous injection and tablet formulations of Pfizer's Cerenia for ...